Esther Hinojosa

Statistics

Publications

Citations

594

H-Index

Active since

2016

Affiliations

Hospital de Manises(Current)

Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas

Bellvitge University Hospital

Hospital Universitario Ramón y Cajal

Hospital Universitari i Politècnic La Fe

Esther Hinojosa is an author at Hospital de Manises specializing in inflammatory bowel disease, inflammatory bowel disease therapy, and pharmacotherapy.

Publications per year

2016–2022

Publications

Short and long‐term effectiveness and safety of vedolizumab in inflammatory bowel disease: results from the ENEIDA registry

María Chaparro, Ana Garre, Elena Ricart et al. · Alimentary Pharmacology & Therapeutics · 2018 · 100 citations · Full text

Pharmacy, Clinical Sciences, Pharmacotherapy +15

Effectiveness and Safety of Ustekinumab in Ulcerative Colitis: Real-world Evidence from the ENEIDA Registry

María Chaparro, A Garre, Marisa Iborra et al. · Journal of Crohn s and Colitis · 2021 · 81 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +15

Incidence, Clinical Characteristics, and Management of Psoriasis Induced by Anti-TNF Therapy in Patients with Inflammatory Bowel Disease

Iván Guerra, Tamara Pérez-Jeldres, Marisa Iborra et al. · Inflammatory Bowel Diseases · 2016 · 78 citations · Full text

Medicine, Immunology, Pharmacotherapy +15

Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn’s Disease Patients: The SUSTAIN Study

María Chaparro, Iria Bastón‐Rey, E Fernández-Salgado et al. · Inflammatory Bowel Diseases · 2022 · 61 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Effectiveness of adalimumab for the treatment of ulcerative colitis in clinical practice: comparison between anti-tumour necrosis factor-naïve and non-naïve patients

Marisa Iborra, Javier P. Gisbert, Marta Maia Boscá-Watts et al. · Journal of Gastroenterology · 2016 · 61 citations

Medicine, Clinical Sciences, Immunology +13

1–5 of 13